You are strongly implying the data is bad, which i
Post# of 148187
So either you’re soft bashing or a shitty writer.
Quote:
We just got access to the Amarex data. Until we did, no one at CytoDyn knew how bad it was - shareholders still don't. Worse data implies longer time to revenue.